Mushrooms with Therapeutic Potentials

Recent Advances in Research and Development

Dinesh Chandra Agrawal, Muralikrishnan Dhanasekaran (Herausgeber)

Buch | Softcover

509 Seiten

2024 | 2023 ed.
Springer Verlag, Singapore
978-981-19-9552-1 (ISBN)

Artikel merken

The book presents new and novel perceptions about ailments alleviating the effects of several mushroom species. Also, the book highlights the curative role of medicinal mushrooms on some peripheral and central diseases. Various chapters in the book (primarily reviews) have been dedicated to providing the therapeutic efficacy of mushrooms against respiratory illnesses, gut microbiota, COVID-19, dementia, epilepsy, mental ailments, cancers, cardiovascular, kidney-related diseases, and other common pathologies. Thus, medicinal mushrooms are current and future consumable healthcare products that usually exhibit nourishing properties and possess prophylactic and therapeutic values with minimal adverse effects and contraindications. The book focuses on Sustainable Development Goal (SDG 3) to promote healthy lives and well-being for all.

Medical, pharmacy, nursing, and CAM (complementary and alternative medicine) students, practitioners, scholars, researchers, other healthcare professionals, and general readers are this book’s potential audience. The book can be adopted as a textbook for undergraduate and graduate courses so that the therapeutic potential of mushrooms can reach a wider audience. This book strives to create a new resource for the future use of medicinal mushrooms in various disorders.

Dr. Dinesh Chandra Agrawal, Ph.D., is a professor in the Department of Applied Chemistry, at Chaoyang University of Technology (CYUT), Taiwan. He has more than 40 years of research experience in the biotechnology of diverse species, including medicinal plants and mushrooms, and has more than 200 publications, including 8 books (6 by Springer Nature). Professor Agrawal has been bestowed several prestigious awards and fellowships, including the Alexander von Humboldt Fellowship (Germany), DBT Overseas Associateship to USDA, Mississippi State (USA), British Council Scholar (UK), European Research Fellow (UK), and INSA Visiting Scientist (India). Currently, Professor Agrawal is serving as Associate Editor-in-Chief of the International Journal of Applied Science and Engineering (Scopus) Dr. Muralikrishnan Dhanasekaran, Ph.D., is a Professor in the Department of Drug Discovery and Development at Harrison School of Pharmacy, Auburn University, USA. He has more than 90 peer-reviewed international publications and several book chapters and is a reviewer in various peer-reviewed journals. Dr. Dhanasekaran’s lab and research interests are in preclinical research and drug development in neuropharmacology. His current research involves elucidating the neuroprotective and neurotoxic effects of botanicals and synthetic compounds; discovering and developing drugs/compounds targeting Alzheimer’s and Parkinson’s diseases.

Chapter 1. Mushrooms as Promising Therapeutic Resources: Review and Future Perspectives.- Chapter 2. Medicinal Mushrooms for Respiratory Health.- Chapter 3. Therapeutic and Prophylactic Potential of Medicinal Mushrooms in COVID-19.- Chapter 4. Influences of Edible Mushrooms on Dynamic and Diversity of Gut Microbiota.- Chapter 5. Mushrooms – From Traditional Remedies to the Modern Therapeutics.- Chapter 6. Biopharmaceutical Potential of Ophiocordyceps sinensis for Human Health.- Chapter 7. Anticancer Potential of Ganoderma lucidum and İts Relevant Modes of Action.- Chapter 8. Cognitive Enhancing Effects of Medicinal Mushrooms: A Potential Neuroprotective Implication in Dementias.- Chapter 9. Potential of Medicinal Mushrooms in Human Health and Welfare: An Overview.- Chapter 10. Mycotherapeutics Reduce Nephrotoxicity and Renal Diseases.- Chapter 11. Proteomic Research on the Therapeutic Properties of Medicinal Mushrooms.- Chapter 12. Cordyceps militaris (L.): Medicinal aspects in terms of ethnobotanical and pharmacological perspectives.- Chapter 13. Mycotherapeutics Affecting Dopaminergic Neurotransmission to Exert Neuroprotection.- Chapter 14. Biological Activities of Some Edible Mushrooms.- Chapter 15. Nephroprotective Effects of Four Ganoderma Species.- Chapter 16. Mechanisms Involved in Edible Mushrooms' Health Beneficial Effects.- Chapter 17. Mycotherapy (Medicinal Mushrooms) as a Potential Treatment for Epilepsy.- Chapter 18. Natural vs. Synthetic Psilocybin: The Same or Completely Different?.- Chapter 19. Preventative and Curative Properties of Reishi and Maitake Mushrooms in Cancer.

Erscheinungsdatum	27.04.2024
Zusatzinfo	1 Illustrations, black and white; XX, 509 p. 1 illus.
Verlagsort	Singapore
Sprache	englisch
Maße	155 x 235 mm
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
Themenwelt	Medizin / Pharmazie ► Pharmazie
Schlagworte	Cancer • clinical studies • Clinical Trials • Covid-19 • Diabetes mellitus • Medicinal mushrooms • neurodegenerative diseases • Preclinical and translational research
ISBN-10	981-19-9552-4 / 9811995524
ISBN-13	978-981-19-9552-1 / 9789811995521
Zustand	Neuware